Serum Institute of India to also halt trial of the Oxford-AstraZeneca vaccine candidate

AZ on Wednesday morning said that it was temporarily halting the trial of the vaccine candidate after one of the participants developed "unexplained illness" in the UK.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZjTnhn
via IFTTT

0 comments:

Post a Comment